WALANT know more?

Carpal tunnel release, trigger finger release, cubital tunnel release, ganglion excision, de Quervain's release: these are done under local anesthetic with epinephrine, with no tourniquet, no sedation and no anesthesia team. Sixty to eighty percent of the operations in a typical hand clinic qualify. In a hospital or an ambulatory surgery center, those cases carry a facility fee that is many times the surgeon's professional fee. In the office there is no facility fee. The patient pays less, the surgeon is paid for the setting as well as the surgery, and the main operating room is kept for the cases that need it.

The pattern is familiar. Most independent hand surgeons are tied to a surgery center, as part-owners or as the surgeons who fill its lists. The center collects the facility fee. The surgeon collects a professional fee for a case that could have been done in a chair down the corridor. Everyone in the room knows it. The question is whether the office pays.

It does, and the patients say so. When Heritage offered every office-eligible patient the choice of the office or the main operating room, nine in ten took the office. Four in five of the Medicare patients paid a $350 fee for the setting to do so, with nothing to save by it: the hospital would have cost them no more. That fee is one practice's arrangement and its legal position is not settled, which the economics page says plainly. The signal is in the choosing. We have been sending patients to the operating room by default, and they have told us, in a financial language that cannot be faked, that the default is wrong.

You do not have to be independent to start. The first office procedure room in this story was set up inside Michigan State University in 2016, by an employed surgeon, in a health-system professional building, with no facility fee attached. The practice described below is what happened when that surgeon left the university to test the office on its own.

None of this is new. By the middle of the twentieth century hand surgeons were already trying to clear large volumes of hand trauma the same way: in 1950 the Accident Department at Guy's Hospital in London ran a policy of wide-awake hand trauma care under local anesthesia, without epinephrine, to streamline the service (Clarkson 1950). The chapter that records it, by this site's author, sets the 1950 photographs beside his own office in 2020 and asks: have we really come so far?

Fourteen advantages, each with the paper that measured it. None is an opinion.

What patients say about it, and how to take the fear out of it, has a page of its own.

A timeline

Around 1900: the standard is imposed

Antiseptic methods had come first. Lister's carbolic acid was antisepsis: killing the germs already in and around the wound. Semmelweis's work was obstetric. His handwashing in chlorinated lime was for doctors examining women in labour, and it cut puerperal fever, but it was not a surgical technique. By the turn of the century the German and American aseptic ritual of heat sterilisation, gowns and gloves was spreading through hospitals, and it was becoming the standard for every operation. For soft-tissue surgery it was good enough. For bone it was not.

Why plates failed the standard

Surgeons who put metal into fractures found that the ordinary rules did not hold. Lane's 1909 paper names the problem: "the danger of the rubber glove is the possible presence of a puncture through which infection might enter the wound" (Lane 1909). The committee's 1912 report says the same thing in its conclusions: a considerable proportion of operative failures were due to wound infection, even with the best technique (Committee 1912).

A method others could not copy

Lane's answer was a different discipline, not a bigger room. In the 1890s he developed long instruments so that the gloved hand did not touch any part of the wound. That is the no-touch technique, and it was in use alongside his fixation work, which began with screws and wires in 1892 (Brand 2009). Sterilised cloths on the incision edges kept the skin out of the field (Committee 1912). The name came later. The committee put the difficulty plainly: fracture treatment "requires special skill and experience", and it should be done only by those with "constant practice and experience in such surgical procedures" (Committee 1912). Few surgeons had that practice, and the method did not spread with the ritual. The fixation of fractures was also met with "violent opposition", which faded only when X-rays showed high non-union rates in the alternatives (Brand 2009).

Plates fall from favour for five decades

For much of the first half of the century, fixation stayed controversial. The method that brought them back was not the old no-touch discipline but a cleaner room. In the 1960s John Charnley's group at Wrightington ran hip replacements through four phases of cleaner operating-room air. Among 2,085 consecutive hips, deep infection fell from 8.9% in the conventional rooms to 1.3% in the cleanest phase (Charnley and Eftekhar 1969). It was an observational study, and the authors could not rule out better wound closure as a cause.

A randomised trial followed in 1982. In hip and knee replacement, deep sepsis was 0.6% with ultraclean air and 1.5% with conventional ventilation (Lidwell 1982). That is the one randomised trial of an environmental control on implant surgery that I have found.

The standard becomes industrial

What began as a response to massive implants has become the standard for every operating room. Clean-air rooms, accreditation rules and monitored theatres now apply to the whole room, whatever is done in it. The ritual is applied to all surgery, and the infrastructure around it is part of what makes an operation cost what it does.

Where hypersterility is needed

The case for the full standard is strongest where a large foreign body goes into the patient. Total hip and total knee replacement are the clearest examples, and the Lidwell trial is about them. Breast implants are another. Infection after breast implant placement is a recognised problem in the plastic surgery literature, and no-touch methods are advocated for that reason. A 2022 systematic review of the Keller funnel, a no-touch insertion device, found six studies, five of them retrospective and none randomised. It reported lower capsular contracture (RR 0.42), and its abstract gives no infection figures (Keller funnel review 2022). A no-touch breast reconstruction series reported no surgical site infections in 25 breasts against two infection failures in 16 earlier breasts, a small before-and-after comparison (Wilson 2015).

Where the evidence runs out

Outside large implants, the evidence that the full standard is needed is missing. The AORN appendix lists 165 references, and by my reading thirteen report an infection outcome. Most of the rest measure bacteria on plates, gowns, gloves and drapes (AORN). The randomised trials with a surgical infection outcome test a wound device, not sterile technique (Bressan 2018; De Pastena 2020). No trial in this history compares sterility levels for simple surgery without implants.

The thesis

The argument from this history is that the strict standard was built around implants, and that it is applied to surgery that does not need it. Where the operation is not a massive prosthesis and does not need anaesthesia support, intravenous fluid support, muscle paralysis or major regional anaesthesia, office sterile-field technique may be good enough. The candidate areas are musculoskeletal, urological, vascular, ENT, ophthalmic, lumps and bumps, general, dermatological and lower gastrointestinal surgery. Each has its own risks, and sterility is only one of them. The case for each has to be made separately.

This is a hypothesis. Its test is a comparison that does not yet exist: the same procedure, done in the office and in a full theatre, with clinical infection as the outcome and the criteria set in advance.

There is a harm side to this as well. Every step up in sterility adds cost, and the cost lands on patients and on the system. Where a step has not been shown to help, it is cost without a benefit, and the argument here is that this is the position for simple surgery. A system built around the strictest standard also brings its own risks: a complex institution, and routine general anaesthesia as part of the way care is delivered, even where the operation does not need it. For an ageing population, the simplest safe setting for simple surgery is a non-institutional room, with the patient awake. The principle is primum non nocere, and it argues for the simpler option where the simpler option is shown to be adequate.

The rhyme

For most of the twentieth century, hand surgery was taught a rule: never inject epinephrine into fingers, nose, penis or toes. Lalonde calls it "a mythical rhyme" that even the weakest medical student could remember (Lalonde 2017). Its origins are older than the evidence. Procaine, the only local anaesthetic before 1948, was blamed for finger necrosis that the epinephrine got the credit for. Phentolamine, the rescue agent, was invented in 1957, after the myth had set into the textbooks.

The review that counted

In 2001 Keith Denkler reviewed the literature on finger injection. He found 48 cases of finger death attributed to local anaesthesia over 120 years, and none involved lidocaine with epinephrine (Denkler 2001). Lalonde's account is that this review is what made the rule untenable.

Watching it done

As a medical student in 1975, Lalonde watched Patrick Shoemaker at Queen's University inject epinephrine into fingers for flexor tendon repairs. Robert MacFarlane, known for Dupuytren's surgery, did his finger work the same way. Lalonde describes "a major disconnect between the reality of what was safely being done and what I was reading" (Lalonde 2017).

Testing it, 2003 to 2005

In 2003 Lalonde's group reported that phentolamine reliably reversed epinephrine vasoconstriction in the human finger. Eighteen Dalhousie hand surgeons had two fingers injected three times with epinephrine, and one finger injected with phentolamine (Lalonde 2017). In 2005 the Dalhousie Project reported 3,110 consecutive elective cases of epinephrine injection in fingers and hands, by nine surgeons in six cities, with no phentolamine rescue needed (Lalonde et al. 2005). Lalonde reports no finger necrosis in more than 2,000 of his own cases. These are prospective case series, not randomised trials, and the numbers come from the surgeons who ran the programme.

A method, not only a myth

What the technique became is a set of practical rules: tumescent injection until the tissue is visibly and palpably full, a bicarbonate buffer to reduce the sting (Frank and Lalonde 2012), and active movement checked during the operation. Flexor tendon repair is the clearest example. Intraoperative total active movement examination was used to avoid repair rupture (Higgins et al. 2010). Lalonde's Saint John rehabilitation protocol followed in 2016.

Training two generations

The first book on wide awake hand surgery appeared in 2016, with more than 150 videos. Electronic media did the rest: the ASSH listserv, Vumedi videos, PubMed and Google links to the papers. A Chinese edition, edited by Jin Bo Tang, appeared in 2017. Tang reports more than 5,000 cases in three years without one necrosis (Lalonde 2017). Lalonde names surgeons across Asia, Australia, Europe, Latin America and North America who took the technique up and presented it at their own meetings.

Much less, not much more

Lalonde's summary of the method is a single line: wide awake surgery "is one of the few innovations that requires 'much less' instead of 'much more' in terms of resources and time". The same paper expects that evidence-based sterility will replace "the customary 'more must be better' custom-based sterility practices for non-implant hand surgery", and that most small hand procedures will be done this way by 2050 (Lalonde 2017). That is the bridge to the thesis on this site. Lalonde argues for it from clinical practice, not from a trial of sterility levels.

What the appendix contains

The AORN evidence appendix lists 165 numbered references. Most measure bacteria on settle plates, gowns, gloves and drapes. That is contamination, which sterile technique is designed to reduce, but contamination is not infection. A small number of studies report surgical site infection, and few of those are randomised trials.

Three entries that look like evidence and are not

The table lists Alwitry's cataract mask trial as reporting surgical site infection. Its outcome is bacteria on settle plates, and the paper reports no infective complications (Alwitry 2002). The table describes Romney's paper as a randomised trial. It is a review of the mask evidence (Romney 2001). A German hospital hygiene recommendation is listed as a trial of iodine against plastic adhesive drapes. I could not find that trial on PubMed, and the entry is a guideline.

The trials that report infection

Two randomised trials of a barrier device, the dual-ring wound protector, measured surgical site infection after pancreaticoduodenectomy. In 107 patients with biliary stents, Bressan and colleagues found incisional infection fell from 44.0% to 21.1% (Bressan 2018). In an interim analysis of 212 patients, De Pastena and colleagues found superficial infection at 7% in both arms, and the trial was stopped for futility (De Pastena 2020). The two results disagree. Neither tests sterile technique, airflow or sterile services. Both test a wound device.

What the history shows

The strictest aseptic standard grew up around implants. Lane's no-touch method, written out in his Appendix E to the British Medical Association's 1912 report on simple fractures, was built around the risk of leaving metal in the wound. Lane kept gloved hands and instruments out of the wound, and sterilised cloths on the incision edges kept the skin out of the field (Committee 1912). The committee concluded that operative treatment needs surroundings that "ensure asepsis", and that "a considerable proportion of the failures of operative treatment are due to infection of the wound, a possibility which may occur even with the best technique." Lane's own 1909 paper says the same thing in plainer terms: "the danger of the rubber glove is the possible presence of a puncture through which infection might enter the wound" (Lane 1909). Neither source gives infection rates. Its warning concerns fixation surgery. It does not address soft-tissue surgery, and it is not a comparison of sterility levels.

The thesis

The argument from this history is that office sterile-field technique, which keeps the skin out of the field and gloved hands out of the wound, resembles the early aseptic practice that was used for soft-tissue surgery. On that reading the most rigorous sterile environment is needed most for implants. An office procedure room that does not meet the highest accreditation standards, such as AAAHC or The Joint Commission, could then safely do simple surgery without implants, and should avoid implants. That is a hypothesis to test. It is not a finding.

Where the thesis is weak

The evidence for it is not in the appendix. No trial in the table compares sterility levels for soft-tissue surgery. The only randomised trials that report surgical site infection test a wound device, not sterile technique (Bressan 2018; De Pastena 2020). History shows that the rule was set by implant risk, but it does not show that simple surgery was safe without it. Until a comparison of sterility levels for soft-tissue surgery exists, "safe for simple surgery" is a claim to test.

The one randomised trial on implants

The trial that comes closest to the implant side of the thesis is not in the AORN appendix. Lidwell and colleagues randomised operating rooms to ultraclean air or conventional ventilation in hip and knee replacement. Deep sepsis was 0.6% in the ultraclean-air operations and 1.5% in the conventional rooms (P < 0.001). Whole-body exhaust suits lowered it further (Lidwell 1982). It is an environmental control, not a comparison of skin preparation or gowning, and it is implant surgery. It says nothing about soft-tissue surgery.

Two observational studies on implants

Charnley and Eftekhar followed 2,085 consecutive hip replacements through four phases of cleaner operating-room air. Deep infection fell from 8.9% in the conventional rooms to 1.3% in the cleanest phase. It is an observational study, and the authors could not rule out better wound closure as a cause (Charnley and Eftekhar 1969). Wilson's before-and-after series compared 25 breast reconstructions with expanders done with a no-touch method against 16 earlier cases. The no-touch group had no surgical site infections; the earlier group had two infection failures. The numbers are very small, although the authors report a significant difference (P = 0.025) (Wilson 2015). Both are useful and both are weak as evidence. Neither is a trial.

What would settle it

A randomised trial comparing full sterile technique with a lesser standard, with clinical infection as the outcome, in a defined surgical population. Nothing in the appendix is that trial. Until one exists, the case for sterile technique in low-risk office surgery rests on microbiology, observational series and biological plausibility. The same standard applies to the case for office WALANT, and this site relies on case series for much of its safety argument. The difference is that the site says so.

Where this leaves the guideline

The guideline is consensus advice built on contamination data and expert opinion. Its own appendix does not show that a specific sterile step prevents infection in a given operation. That does not show the guideline is wrong. It shows the evidence behind it is thinner than its authority suggests.

Ask them afterwards and the answer is the same everywhere. In five South African public hospitals, 84 of 85 patients would have WALANT again and would recommend it; their median pain during the operation was zero (Govender 2025). In a Lithuanian day unit 98 percent would choose it again a month later, and 93 percent called it no worse than the dentist (Knystautas 2023). In a randomized trial of headphones during awake surgery, 50 of 50 would choose it again; noise-cancelling headphones halved their anxiety on the table, from 2.3 to 1.0 out of 10 (Townsend 2021). In 154 consecutive patients tracking their own pain, 40 percent felt nothing at all during the injection and 60 percent felt only the first needle; they rated the experience 9.2 out of 10 (Brutus 2025).

Against the surgery center, the office wins on time, not on satisfaction. Knopp 2023 surveyed 151 patients across both settings: satisfaction 9.7 out of 10 in each, but 0.9 days off work after the office against 12.4 after the surgery center. And they go home without opioids: an office series that sent nobody home with a prescription found 2.8 percent asked for one by the next day and 5.6 percent within a week (Sraj 2019).

The honest part. The injection is the part they remember: four in five of one trial's patients called it the most painful moment (Pistorio 2024). Nearly half arrive moderately to severely anxious (Govender 2025). And a block done by an anesthesiologist can beat a hurried WALANT: in one Turkish series using 25 mL and a fifteen-minute wait, the supraclavicular block scored higher on satisfaction, 90 against 80 out of 100, and one awake patient in ten was converted (Azizoğlu 2026). The technique rewards the surgeon who does it properly.

Nobody fears a carpal tunnel release. They fear being awake for it. Nearly half of patients arrive moderately to severely anxious and half fear pain despite the anesthetic (Govender 2025); anxiety is the reason patients are dissuaded from awake surgery (Hoxhallari 2019), the reason 28 percent of surgeons offer it only to "patients who can tolerate being awake" (Grandizio 2020), and the usual reason for the rare conversion. An operating room answers that fear with a sedative. An office answers it with something to look at.

The mechanism is older than the technology. Melzack and Wall showed in 1965 that a competing sensation can close the gate on a painful one. Fun and joy act in opposition to fear and anxiety in the same way, and the hypothesis from this site's author's group is that an immersive experience works on the anxiety axis: a cortical pathway feeding back on the amygdala, the emotional analogue of the gate in the dorsal horn (Park 2023). Whatever the mechanism, a counter-distracting experience, something more interesting than the operation, shatters the apprehension the patient has built up on the way in. Three kinds have been tried in the office: a headset, a pair of headphones, and a screen.

The office at Michigan State University began offering patients a virtual reality headset during awake hand surgery in 2016. Three studies came out of it.

What the three say together: the headset does not change the operation and does not change the pain, except at the needle in the anxious. What it changes is the fear, and it changes it most in the people who have the most of it. Those are the patients who would otherwise ask for the operating room. Nearly three-quarters of the patients with an anxiety disorder chose it when offered.

How it is done, from the papers. A consumer headset and free 360-degree films; the early phone-in-a-headset kits overheated and were superseded, and the later stand-alone headsets needed the patient seated, because their view could not be re-centered for someone lying down. Choose films for engagement and against spatial motion, offer a choice (one water-phobic patient was given an underwater film and hated it), and let the room follow on a laptop so the team sees what the patient sees. Time the injection to a moment of relief in the film. Offer the headset for the injection to the needle-phobic and for the operation to everyone; cooperation with "make a fist" is immediate. Excluded in the trial: seizures, pacemaker, vertigo, a plastic allergy, severe short or long sight, anyone unwilling to wear a band. Expect one in three to have some small difficulty, usually glasses or the content, and the oldest patient in the trial, over 82, to dislike it; one patient would rather have talked to the surgeon.

One patient's sentence, from the second study: "I was very skeptical at first, but knowing I was going to have a virtual reality experience for my second surgery made me much more relaxed pre-op."

Disclosure: this site's author was co-founder and Chief Medical Officer of Wide Awake VR, the company behind the headset used in these studies, and the studies declare it. The 2019 randomized trial declared no financial interest.

The hand-trauma chapter puts it in one line: wide-awake virtual reality is a technique, not just a technology. The headset does not remove the surgeon from the relationship; it recontextualizes the experience for the patient, provided the technique is right. The chapter's rules, condensed:

• Use it to get the patient into the chair. "Just put me out, doc." "How about I put you in another place, using virtual reality? It means we can fix your hand now. Would you be willing to try?"
• Start early. Give the patient time in the headset before the surgery begins, to orient, pick what they want to watch and start enjoying themselves. The needle-phobic and children need it on for the injection, with the countdown from three and the skin pinch as usual.
• Choose the content with them. Ask about motion sickness and choose sedentary material for anyone who has it; ask about fears (water, heights) and musical taste; avoid roller coasters and flight with roll, pitch and yaw; stabilized drone footage with a level horizon is well tolerated. Passive immersive experiences and music have worked best; about two and a half hours of media covers a list.
• Keep control of it for most patients, who are new to the technology; let the experienced ones drive.
• Announce yourself. On entering the room, introduce yourself and touch the shoulder before surgery starts.
• Maintain immersion. A well-immersed patient looks around, and their breathing becomes slow and deep. If their attention drifts to the surgery, bring them back: ask where they are, what they can see, whether to move on to the next experience; use humor about the content.
• Keep talking. They can hear everything said in the room unless they are wearing headphones. Use the show to re-context the conversation and give the postoperative advice while they watch; education embedded in the content is retained because the patient is calm.
• Headphones are wanted by a definite minority; surgical sounds alone have caused syncope. Noise-cancelling headphones also make teaching a resident easier, at the cost of the patient hearing your commands.
• Expect up to a third to decline. That is normal. Beware the very anxious patient who also declines; encourage a trial run before deciding, and accept that a very anxious patient who still declines may not be suitable for awake surgery.
• The most anxious benefit the most, in both the randomized trial and the patient-reported study. White-coat hypertension often normalizes in the headset, which makes the epinephrine injection safe to give.
• Supine is a problem for consumer headsets, which expect the user upright and looking forward; medical devices now re-center the gaze for a patient lying down.

The chapter also reports the office's own quality-improvement numbers for the first half of 2023: of 230 patients who had WALANT in the office between January and June, 80 percent chose the headset. Of those, 95 percent said it reduced their anxiety during the procedure; overall satisfaction with the experience was 9.7 out of 10 with the headset against 9.3 without (p = 0.03), and enjoyment 8.1 against 5.9 (p = 0.0001).

For balance: a 2026 systematic review of the seven randomized trials of virtual reality in adult hand and wrist surgery (543 patients, 2019 to 2025) found that the headset did not consistently reduce pain, that three of the six trials measuring anxiety found it reduced intraoperative anxiety, and that the certainty of the evidence was low on both counts; it concluded that virtual reality may reduce intraoperative anxiety in selected patients and called for larger trials stratified by baseline anxiety (Bhindi 2026). That is the same conclusion the three Michigan studies reached from the inside: it is a treatment for fear, and it works best on the people who have the most of it.

The headset is not the only way, and not the cheapest. In a randomized trial of 50 awake hand-surgery patients, noise-cancelling headphones playing the patient's own music halved anxiety on the table, from 2.3 to 1.0 out of 10, and every one of the 50 would choose awake surgery again (Townsend 2021). Headphones cost less than a dressing pack, fit over glasses, and leave the eyes free to watch or to close. A 2026 meta-analysis of 25 randomized trials of music around surgery found a moderate reduction in anxiety, and the largest effects under local or regional anesthesia (Yu 2026).

A screen is the third option: a television on the wall, a tablet on an arm, a projector on the ceiling, playing what the headset would, with nothing on the patient's face and the surgeon and patient still able to see each other. It suits the patient who wears glasses, the patient who refuses a headset, and the 82-year-old who wants a conversation. It is the least studied of the three in hand surgery, and the trials that exist are worth knowing before you buy one:

• In 115 office patients having small operations on the face, wrist or hand, a distracting video played during the injection of the local anesthetic lowered injection pain by one point out of 10 (p = 0.01). Satisfaction did not change (Molleman 2019).
• In 50 awake orthopedic day-surgery patients under local or regional anesthesia, randomized to a film through video glasses or to music of their choice through headphones, both reduced anxiety, and the music reduced it more (p = 0.018). Neither changed pain (Demirci 2023).
• In 152 patients having ingrown toenail surgery under local anesthetic, a bedside audiovisual program reduced neither pain nor anxiety, and was no better than conversation with the staff (Drahota 2008).
• In 476 cataract patients, twenty minutes of television before surgery cut intraoperative hypertensive events in first-time patients from 10.3 percent to none (p = 0.003); television and music both lowered pre-operative anxiety by a similar amount (Cheng 2026).
• A systematic review of 20 randomized trials of distraction during surgery under local anesthetic found that 30 percent showed a benefit, 50 percent showed none, and that relaxation-based methods may do more for intraoperative anxiety than audiovisual ones (Hudson 2016).

Read together: a screen takes the edge off the needle and settles the patient before they come in, music does at least as much for anxiety on the table, and the headset is the only one of the three with hand-surgery trials showing it reduces anxiety during the operation itself. The screen earns its place as the fallback for the patient who will not or cannot wear anything on their face. Jean Paul Brutus runs a music and light show during surgery in Montreal (Brutus 2022); the principle is the same in all of them: give the mind somewhere better to be.

An operation is the same in every office. The experience is not, and patients talk about the experience. The Centers for Medicare and Medicaid Services scores outpatient surgery on patient-reported experience through its consumer survey, but that survey reaches hospital outpatient departments and surgery centers. It does not reach the private office. Nobody scores your office, which cuts both ways: there is no published number to defend, and none to hide behind either. What a private practice has instead is what the patient tells the next person. A practice that sends a patient home at eleven in the morning having spent the operation drifting down a river in a film has given them a story, and the story is the referral. The surgeon who fitted the headset is the one they remember. It costs a consumer headset or a pair of headphones, and it is the cheapest marketing a practice will ever do.

In 2010, 1.2 percent of the carpal tunnel releases done under local anesthetic in the United States were done in an office. By 2020 it was 3.4 percent: 5,463 office cases against 303,741 in an operating room. The office patients filled fewer opioid prescriptions, went to the emergency department less, and had the same infection rate (Kammien 2024). Across the four commonest office operations the share is still rising, and total cost in the office runs 30 to 48 percent lower whatever the payer (Kammien 2026). None of that has moved the number past a rounding error.

Ninety-seven in a hundred of the most common operation in hand surgery are still done in a building that charges a facility fee for it. That is not a verdict on the office. It is the size of the room you are walking into.

The surgeons have been asked why. When 869 members of the American Society for Surgery of the Hand answered a survey, 62 percent said they used WALANT, but only 24 percent used a clinic procedure room for it, and nearly half said their institution required anesthesia staff to be present for an awake case. The commonest reason given for not using it was a preference for the tourniquet, or worry about seeing the field without one, at 16 percent. Fear of epinephrine was 2 percent (Grandizio 2020). The barrier is habit and institutional rules, not the evidence. Elsewhere the dogma itself survives: of 398 orthopedic surgeons surveyed in Pakistan in 2025, 80 percent used lidocaine with epinephrine somewhere, and 52 percent still believed it should not be used in a finger or toe (Shah 2025).

In April 2025 the surgeon rented half a practice building, hired three and a half staff and fitted two procedure rooms, one for surgery and one for imaging. One day a week at a rural hospital, running a hand clinic and an operating list as a contractor, paid the bills while the office found its feet. Everything below was built with no institutional facility, no surgery-center ownership and no referral contracts.

That is one surgeon's own volume at contracted rates, collected on a standard revenue cycle: patients pay on the day, and 97 percent of insurance arrives within 120 days. The start-up capital and the day job are in none of it. The $322 an hour is the number to remember. You had better be in your office.

The professional fee is not quite identical in the two settings, because the office is paid at the non-facility rate, but for most hand codes the difference is negligible: one claims study found the surgeon paid 3 to 9 percent less in the office by commercial payers and 5 to 13 percent less by Medicare (Kammien 2026), another found the surgeon paid more, $515 against $472 (Lalchandani 2019). A few tens of dollars either way. What the office does not carry is a facility fee. Heritage went one step further and asked the patients who chose the office to pay for the setting itself. That is a separate decision from moving the operation, it carries its own risk, and it is set out here as one practice's arrangement rather than as a model to copy. Every patient was given three doors, and the main operating room was always one of them.

Everyone using their insurance was quoted the same $350, and the main operating room stayed open to all of them at no extra charge from the surgeon. Heritage tried $500 first; it did not hold. Dr Steven Koehler, in New York City, has presented the same arrangement at $400. Two practices are not evidence of anything except that two practices did it.

One fully self-paying patient is worth more than two insured ones. Same chair, same hour. Only seven of 136 commercial patients took that door, and finding more of them is a marketing problem, not a clinical one: it cost $20,000 over five months to put a price engine in front of patients in one state. One practice cannot outspend a hospital. A network can, and that is what WALANT Surgical Solutions is for. But the office does not need the network to pay its way. It pays on the patients you already have.

An illustration using Heritage's observed rates. Change the figures to your own. It counts cases and operating-room time only: your professional fee barely moves with the setting, and no fee for the setting is assumed.

The cost finding is not one practice's. It has been measured by direct cost, by time-driven costing, by national claims and by what patients and their employers lose, in academic centers, military hospitals, a Veterans Affairs system, a Spanish district hospital and Swedish consulting rooms. It points the same way every time, and the reason is always the same: the building, not the drug. The saving from dropping the anesthetic disappears once the setting is held constant; the saving from dropping the building does not.

Two findings cut against the surgeon, and they belong here. In Germany, where the tariff pays a lump sum for anesthesia, day-case fracture surgery under WALANT was reimbursed 19 to 33 percent less than the same operation under a regional block, although the hospital still came out ahead because the case cost so much less to run (Trautz 2026). And in the United States, Kazmers observed that a group which shares in a facility fee has a financial reason to keep its cases in the building that charges one. Both are statements about who captures the saving, not about whether there is one. In the office there is no facility to capture it.

The two objections to office surgery are sterility and what happens if something goes wrong. Both have been studied, repeatedly, in large series. The sterility demand for a carpal tunnel release is not the sterility demand for a hip replacement, and the literature is clear that field sterility is more than adequate for low-acuity surgery without implants.

Field sterility, as the Canadian multicenter study defined it: prep the hand with iodine or chlorhexidine, the equivalent of a single drape, a sterile tray with modest instruments, sterile gloves and masks, surgeons not gowned, no prophylactic antibiotics.

Three things the office series say that the hospital series do not. Antibiotics add nothing: McKnight's 1,011 cases and Hunziker's 153 fixations had none, and Hunziker's infection rate without them matched the operating room's with them. Ventilation adds nothing at this level of surgery: Tessier's procedure room turned its air over six times an hour against the operating room's 25, with the same infection rate. And the patients who do worse in the office are identifiable: in Carter's 2,182 patients, smokers (23.8 against 6.1 percent) and patients with autoimmune disease (23.3 against 4.7 percent) had more complications in the office than in the operating room. Book them with that in mind.

A 2025 meta-analysis of the eleven randomized trials (794 patients) found complications no different from tourniquet-based anesthesia, with intraoperative pain reduced by more than the clinically important difference; a second, of the carpal tunnel trials alone, put the reduction at 1.6 points out of 10 with no heterogeneity between trials (Chou 2026). The American Academy of Orthopaedic Surgeons' 2024 carpal tunnel guideline states that limited evidence suggests carpal tunnel release may be safely conducted in the office setting, the studies consistently showing no increased risk of complications. Nobody has shown the office makes the operation itself any better. Nobody has shown it makes it worse.

The belief that epinephrine must never go into a finger was never supported by evidence. The whole of it rests on 21 case reports, mostly before 1950, of finger ischemia after injection with procaine or cocaine plus epinephrine; both of those agents caused digital infarction on their own, and none of the 21 had phentolamine rescue attempted (Thomson 2007). The Dalhousie Project, nine surgeons in six cities, then recorded 3,110 consecutive elective injections of low-dose epinephrine (1:100,000 or weaker) into hands and fingers. There was no digital tissue loss in any case, and phentolamine rescue was never needed. A 2015 review of the emergency literature found at least 2,797 digital blocks with epinephrine, twelve of the studies randomized, and no necrosis (Ilicki 2015). Six years of Texas poison-center calls recorded 213 accidental auto-injector injections into fingers, at 1:1,000, ten times the surgical strength; every patient with follow-up recovered fully and none needed surgery (Muck 2010).

The series since say the same. In 1,073 consecutive finger and hand operations in Malaysia, diabetics included, there was no circulatory compromise and phentolamine was never used (Abdullah 2021). In 308 carpal tunnel releases done with undiluted epinephrine, about two and a half times the usual strength, there was no ischemia (Kotb 2023). In 15,595 pooled WALANT patients there was one permanent digital ischemia, after a crush injury (Lawand 2024). What epinephrine does do is measurable and minor: of 387 injections, 2.2 percent produced a brief "adrenaline rush" of palpitations and tremor and 1.8 percent a vasovagal episode (Greene 2021). Fingertip oxygen saturation can fall for a couple of minutes after injection and is normal again within half an hour (Moog 2021). At the full 7 mg/kg dose, serum lidocaine peaks at about 4 μg/mL, under the 6 μg/mL toxicity threshold (Abdullah 2023).

Epinephrine also needs time. The textbook seven to ten minutes is wrong for the skin: in a triple-blind randomized study, the lowest cutaneous hemoglobin after lidocaine with epinephrine came at 25.9 minutes. Inject, then wait 25 minutes before the incision, and the field is dry without a tourniquet.

Bupivacaine is not recommended for office surgery because of its cardiac affinity, and it adds little: after awake carpal tunnel release with or without it, patients used two or three of the thirty tablets prescribed (Diaz-Abele 2019). Keep phentolamine in the room for epinephrine reversal. In the published series you will not use it, and in the one published office-era case you would have: a 74-year-old's finger went cold and blue four hours after a Dupuytren's nodule excision and trigger release, at home, after a normal 40-minute dwell; phentolamine was not stocked and the finger was rescued with urapidil (Frey 2025). The reversal can be given hours later and still work. In a survey of surgical trainees, one in five knew that phentolamine was the reversal agent (Zargaran 2021).

Put the series together and this is the shape of a year's work. Round numbers, because the definitions differ; the papers behind each are in the tables above.

• Smelling salts. Vasovagal episodes are the commonest event in awake surgery, about one in fifty injections, which is why the supine position is preferred.
• Phentolamine, 1 mg in 1 mL, to infiltrate where the local went, repeated if the color does not return. Everybody in the room knows where it is. Every patient leaves knowing that a finger that goes white or blue at home is a phone call, not a wait-and-see.
• An automated external defibrillator (AED), and current basic life support (BLS) training for the surgeon and the team.
• A formal consent, a formal timeout before every case, and a formal operative report the same day. Not being in a hospital is no reason to drop any of them.

The patient is awake, unsedated and has eaten breakfast. There is no airway, no anesthetic clearance, no fasting and no pre-operative labs. Blood pressure at injection moves by about 4 mmHg, against a 20 mmHg fall at induction of general anesthesia (Liu 2022). Most of the physiological risk of a surgical episode is removed before the patient sits down.

WALANT is Don Lalonde's technique, and he is the father of it. Everything on this page builds on his work (Lalonde 2017). My guidelines paper with colleagues at Michigan State on field sterility in the office (Schank 2023) and my hand-trauma chapter (Clarkson and Park) lean heavily on what he worked out. His injection drawings are below (Joukhadar 2021). The literature page gives the numbers behind each step.

Every injectable local anesthetic descends from cocaine and is an ester or an amide. The esters (cocaine, procaine, tetracaine) are broken down by pseudocholinesterase to para-aminobenzoic acid, a known stimulus for hypersensitivity. The amides (lidocaine, bupivacaine, prilocaine, ropivacaine, levobupivacaine) came in the 1940s, work faster, and carry a much lower allergy risk; the rare reactions they do cause are usually attributable to the preservative methylparaben, which can break down to the same acid, so a patient allergic to esters gets a preservative-free amide. True anaphylaxis to lidocaine is extremely rare against an estimated two billion injections since 1948. A rule of thumb from the chapter: an amide has two letter i's in its name. The trap is the trade name Marcaine, which is bupivacaine and an amide. Caution is advised when amides are used alongside macrolides such as erythromycin, HIV protease inhibitors, azole antifungals such as itraconazole, and verapamil.

The two amides hand surgeons use are lidocaine, swift in onset and shorter in duration, and bupivacaine, slower to take effect, longer lasting and more cardiotoxic. Bupivacaine gives up to eight hours of anesthesia to pain, and numbness to touch and pressure for twice that, which is why many physicians consider it less suitable for office use; its myocardial affinity can cause fibrillation before any central nervous system warning appears. I don't use it in the office, and most WALANT surgeons don't either. Lidocaine works by blocking voltage-sensitive sodium channels; it must be water-soluble to travel through the tissue and lipophilic to cross the myelin, so each molecule has a hydrophilic amine end and a lipophilic aromatic ring. Infected, inflamed tissue defeats it twice over: the acid environment ionizes a weak base so that it cannot cross the axon membrane, and the hyperemia washes it away. Inject proximal to and around inflamed tissue, not into it.

The classical safe dose of lidocaine is 4 mg/kg without epinephrine and 7 mg/kg with it. Each milliliter of 1% lidocaine holds 10 mg, so a 70 kg adult can take about 50 mL of 1% lidocaine with epinephrine. That ceiling comes from conservative estimates made in the 1950s; tumescent liposuction has since used up to 28 mg/kg (Klein 2016, cited in Schank 2023), which assumes third-space sequestration and the removal of part of the solution by suction. I don't go above 7 mg/kg in the office. Away from a hospital, toxicity can't be managed as well. For a bigger field, dilute rather than exceed it: 1% lidocaine with 1:100,000 epinephrine and bicarbonate can be made up to 200 mL with saline and still works, for a shorter time. Bupivacaine is 2 to 3 mg/kg with or without epinephrine, because its action outlasts the epinephrine. Injection site, pregnancy, epinephrine, and cardiac, renal or hepatic disease matter more to the plasma level than body weight does.

Lidocaine toxicity announces itself: perioral numbness, facial tingling and a metallic taste. At higher doses it progresses to tonic-clonic seizures, then ventricular fibrillation and cardiac arrest. Bupivacaine can produce ventricular arrhythmia heralded by a prolonged PR interval and a widening QRS. In a cardiac arrest or seizure the advanced cardiovascular life support protocol is followed, with prompt airway management, intravenous fluid and defibrillation; vasopressors may be needed to support coronary perfusion; amiodarone is chosen over lidocaine for arrhythmia; seizures are managed with benzodiazepines; and electromechanical dissociation may be rescued with lipid emulsion, which extracts the lipophilic drug from the myocardium. None of this has been needed in any office series read for this site, which is the reason to know it rather than a reason not to.

Local anesthetics are mildly acidic, pH 3.3 to 5.5, and the acidity is part of the sting. A Cochrane review of 23 randomized trials found buffered lidocaine less painful to inject by one to two points out of 10, and preferred by patients three to one (Cepeda 2010; the review was later withdrawn under Cochrane's sponsorship policy, not over its findings), and the WALANT trials since agree: injection pain 2.2 out of 10 buffered against 5.8 plain (Kang 2019), and fewer complications in the buffered studies when pooled (Lawand 2024). The mixture in both publications is 9 mL of 1% lidocaine with 1:100,000 epinephrine and 1 mL of 8.4% sodium bicarbonate, which brings it to about pH 7.3; 2% lidocaine needs only 0.5 to 0.6 mL per 10 mL, and bupivacaine and ropivacaine must never be buffered, because they precipitate (AlShammari 2025). Warm the refrigerated solution before you draw it up. A buffered syringe keeps for two weeks; the 1:200,000 premix sold in Europe works, but gives a less dry field (Amin 2020).

Twentieth-century dogma held that epinephrine was forbidden in the finger because of the risk of thrombosis of the digital vessels. The dogma was built on case reports of fingers injected with procaine or cocaine, agents that caused infarction on their own; the evidence is on the safety page. In Sterling Bunnell's phrase, a jeweler cannot repair a watch in a pool of ink, and hand surgery has always wanted a bloodless field. Putting epinephrine back into the hand is what let the tourniquet go, and the tourniquet was the reason awake surgery hurt. I have counted the papers that established its safety, and the ischemic events reported since 2012: six case reports. Vascular observation is still required. I have seen one case myself, a fingertip that necrosed after epinephrine in a finger crushed seven weeks earlier, salvaged with hyperbaric oxygen (Engwall 2021).

Two more cautions. Patients with severe cardiovascular disease may be better served by a reduced dose and a monitored setting, although there are series reporting safe use; and, on animal evidence, caution is advised for patients taking tricyclic antidepressants or serotonin-norepinephrine reuptake inhibitors. One warning is sharper than the chapter's table, and it comes from this site's author's own practice: a patient whose coronary artery disease is not controlled, who still gets breakthrough angina, should not be given epinephrine at all. He has induced angina with it, infiltrating 1% lidocaine with 1:200,000 epinephrine at 7 mg/kg beneath a calciphylaxis eschar on a medial thigh — a large field, a full dose, and a patient whose heart had no margin. Personal communication, Clarkson 2026. Warn every patient that they may sense the drug: fearfulness, shaking and palpitations, a brief "adrenaline rush" that frightens only the patient who was not told. It happened after 2.2 percent of 387 injections, and a vasovagal episode after 1.8 percent (Greene 2021). The chapter injects with the patient sitting up and lies them flat, legs raised, the moment they report nausea or faintness; most WALANT surgeons inject supine from the start.

Phentolamine reverses epinephrine. Inject 1 mg in 1 mL into the site where the local went, and repeat if the color does not return; the one time I have used it, after a vessel was found injured during a tendon repair in the main operating room, the white fingertip pinked up twenty minutes later. Dusky or blanched fingertips at the end of a case are a common early finding, and the surgeon does not discharge the patient until perfusion improves. Every patient leaves knowing that a finger that goes white or blue at home is a phone call, not a wait-and-see.

The equipment is a 10 mL syringe (which holds 11), a 27- or 30-gauge needle, 9 mL of 1% lidocaine with 1:100,000 epinephrine buffered with 1 mL of 8.4% bicarbonate, and phentolamine within reach. Delivery through a 3 mL syringe can help with the first, slow part. The sequence, from the guidelines' table of technique:

1. Warm the refrigerated solution.
2. Count down verbally from three. The patient takes a deep breath at two.
3. Pinch the skin at the moment of injection and keep pinching until the needle pain has gone.
4. Inject slowly with a stable needle, held in two hands, the thumb already on the plunger.
5. With the needle at 90 degrees to the skin, raise a bleb of 0.5 to 1 mL, then rub the tumescence for 30 seconds.
6. Inject the rest over 60 seconds with the needle at a more tangential angle, keeping the tip within the swelling you have already made, and work outward, slowly.
7. It is reasonable to inject more than you think you need.
8. Wait 20 to 30 minutes, and do not rush.

Lalonde's thirteen rules for a painless injection, drawn by his group, say the same thing in pictures. Buffer the local and use a 27- or 30-gauge needle. Pinch the skin up into the needle rather than pushing the needle down into the skin, and pinch just proximal to the entry so that the sensory noise arrives first. Go in perpendicular, which irritates fewer nerve fibers than an angled entry. Do not inject into the dermis; put at least 2 mL slowly into the fat just beneath it before the needle moves at all. Never advance a sharp tip into tissue that is not yet numb: keep a centimeter or two of visible, palpable swelling ahead of it, and re-enter only through skin that is already white. Work from proximal to distal relative to the nerves. Use a blunt cannula for large areas. Ask the patient to tell you every time they feel anything, and score yourself. Done this way, 85 to 90 percent of patients feel nothing after the first poke (Billard 2025); the three surgeons who scored themselves on 154 patients found that 61 felt nothing at all and only one felt pain more than once (Brutus 2025).

How much to use. One percent lidocaine is the concentration in 49 of the 60 studies that state one (Lawand 2024). Volumes run from 3 mL for a trigger finger to 40 mL for a cubital tunnel, and the series are consistent:

The finger. The digital block is the exception to the tumescent rule. Put no more than 2 to 3 mL of the buffered mixture between the digital bundles, with the needle at 90 degrees, so that the vessels are not compressed by the volume. For dorsal anesthesia proximal to the proximal interphalangeal joint, add a dorsal injection of 3 mL. A local ring tourniquet is well tolerated if you want one.

The forearm and other large fields. Dilute 50 mL of the buffered 1% mixture up to 200 mL with saline; it keeps acceptable efficacy for a shorter time. Tumesce the entry point with a 27-gauge needle, then fill the region through a blunt cannula. Expect a zone of vasoconstriction inside the tumesced area and more bleeding beyond it, where the nerves are blocked but the epinephrine never reached.

Paradoxical bleeding. Vasoconstriction happens only where the epinephrine sits in the interstitium around the capillary bed. A proximal injection paralyzes the sympathetic fibers to the digital vessels, so a finger beyond the tumesced zone can bleed more, not less, despite the epinephrine upstream. Densely fibrotic tissue does the same, because the drug cannot perfuse it; the stiff hand at tenolysis is the classic example. The answer is to tumesce the field you are cutting, not the field you are blocking.

Metacarpal fractures and K-wires. Tumesce around the fractured metacarpal and the planned wire entry points, dorsal and volar, and make sure the metacarpals on either side are inside the tumesced zone, so the wire is not felt as it drives into the adjacent bone.

Infection. Inflamed tissue ionizes lidocaine and washes it away; tumesce proximal to and around the inflamed area rather than into it. The wait. The textbook seven to ten minutes is wrong for the skin: the lowest cutaneous blood flow after lidocaine with epinephrine comes at about 26 minutes (McKee 2013, cited in Schank 2023), and the series that did not wait paid for it. One teaching hospital needed a tourniquet for hemostasis in 90 of 416 cases (Gabay 2025), and the single study arguing that seven minutes is enough, 17 patients per arm, put all three of its complications in the seven-minute arm (Hernandez 2020). The alternative, local with an arm tourniquet, doubles the discomfort for the same operative time: 3.6 against 1.7 out of 10 in a randomized trial (Saleh 2021). The objection that a ten-minute release does not justify a half-hour wait has an answer: batch.

My routine for a list: bring the first two or three patients in together, thirty minutes before the start. By the time the second and third have been injected it is time to start the first, and the surgeon stays one or two patients ahead all afternoon, with later patients arriving for their block between cases. In my practice a midlevel provider or a qualified resident gives the blocks in two clinic rooms separate from the procedure room, and the surgeon moves on to the next case while a midlevel or resident closes and dresses. One medical assistant circulates; the surgeon may scrub alone.

Antibiotic prophylaxis is not needed for hand surgery without an implant, and the evidence is now good that it adds nothing even with one: 153 hand and wrist fixations done without antibiotics in an outpatient theatre had the same infection rate as the main operating room's with them (Hunziker 2025), and the two largest office series gave none. Where a cephalosporin is wanted, the oral route gives 90 percent of the bioavailability of the intravenous one.

The room runs on three people. Lalonde's unit does three carpal tunnel releases an hour with one surgeon, one nurse and one receptionist (Degreef 2024); a Calgary minor-procedure day gets through 10 to 15 cases against three or four in the main operating room (Ponich 2025); a surgery center ran 1,771 consecutive awake cases with one nurse monitoring and circulating and no anesthesia provider, without a single abort, conversion or transfer (Schindelar 2022). What the room, the tray and the staff need is on the setting-up page. Which operations belong in the office, and which still belong in the operating room, is on the page on what can move.

The awake patient is also a captive, attentive one, and the fear they bring in with them is treatable in the chair. Virtual reality, headphones and music, and a screen are covered on the patient experience page.

The literature on awake surgery runs from trigger finger to shoulder disarticulation. For a surgeon deciding what to move out of the operating room, the question is narrower: what has been done in an office or minor procedure room, in numbers, with the infection and conversion rates reported. That is the first group below. The second group has been done awake in hospitals, often with an anesthesiologist on standby or an overnight bed, and belongs there until someone shows otherwise.

Two entries in the first group come from this site's author rather than from a published series, and are marked as such. Soft-tissue rheumatoid surgery and tendon transfer surgery make excellent office candidates, for two reasons: the frailty of the patient population, for whom an anesthetic is the risk and the operation is not; and the nature of dynamic reconstruction, which is best judged with the patient awake and moving. Extensor hood centralization, extensor tendon transfers, and wrist synovectomy with retinacular transposition are the examples at Heritage Hand and Plastic Surgery and, before it, at Michigan State University. The published awake tendon-transfer series were all done in hospitals; nothing in them argues against the office.

The 2023 office guidelines draw the line at the permanent implant: an operation that leaves one behind belongs under full sterility in an accredited operating room; most of the rest can be done in the office under field sterility (Schank 2023, table 4). Their lists, condensed:

Any exam room can become a procedure room. You need a comfortable place for the patient to sit or lie, a stable surface to operate on, a stand or table for the instruments, good light, and a rolling stool. Like furnishing a house, there is a wide range of taste and budget. What follows is what Heritage bought, with the prices paid. The full paper, with every line item, is open access: Clarkson and Ilyas 2026.

The field is young and it is accelerating. PubMed holds 388 free-to-read papers with WALANT or wide-awake hand surgery in the title or abstract. One was published in 2011. Seventy were published in 2025. The 270 of them whose licence allows the full text to be read in bulk were read, every page, for this site; the other 118 are free to read one at a time at the publisher. What follows is what they say, by theme, and then what they do not yet say.

Of the 388: fourteen randomized trials, four meta-analyses, ten systematic reviews, forty narrative reviews, forty-six case reports, and the rest cohorts and case series. The randomized base is small. The eleven trials pooled in 2025 hold 794 patients between them, follow them for weeks rather than years, and compare the anesthetic, not the building. No trial has ever compared field sterility with operating-room sterility; the equivalence rests on the large cohorts, the national claims, and the Veterans Affairs series that ran both rooms side by side. The claims studies, which supply the biggest numbers, cannot tell whether a case was WALANT at all, only where it was done. The largest office carpal tunnel series are industry registries for an ultrasound-guided device. The narrative reviews re-quote the same fifteen primary studies, and not always accurately, which is why every figure on this site is taken from the primary paper. Four papers print one number in the abstract and a different one in the results; the results are used. One paper that would otherwise be cited, a 2020 randomized trial of distal radius plating, has been retracted and is not.

Two more habits of this literature. Half the technique papers do not say whether they buffered the local, and most do not say whether they gave antibiotics. And the office is rare in it: of the 270 papers read, only about twenty-five report a true office, consulting-room or minor-procedure-room series. Those twenty-five carry the weight of this site.

• No office series places an implant. The fracture fixation data are from outpatient theatres and minor procedure rooms, not exam rooms.
• The office rheumatoid and tendon-transfer entries rest on one practice's experience, reported here as a personal communication, not yet on a published series.
• Flexor tendon repair in a procedure room rests on one series of 93. Distal radius plating is not yet a procedure-room operation, by its own reviewers' account.
• Patients with vascular disease, Raynaud's or scleroderma were excluded from nearly every epinephrine study. The reassurance does not extend to them.
• The wait before incision has never been settled by a trial of adequate size.
• Nobody has shown the office makes the operation itself any better. The outcome data say the same; the preference data say most patients, not all: in a bilateral trial where each patient had one side each way, 59 percent preferred local only and 34 percent preferred sedation (as reported by Stocker-Downing 2025).
• The office infection rate depends on the definition more than on the room, and most series do not say which they used.
• Superficial infection runs higher after double trigger releases (7.3 percent in the largest office series), and complications were commoner in smokers operated on in the office than in the operating room (Carter 2026). Nobody has yet studied why.

In November 2026 this site was checked against every open-access paper on WALANT in PubMed Central, 270 papers read in full, and revised where they added to it or disagreed with it. The ones it draws on are below. One paper that would otherwise have been cited, a 2020 distal radius trial, has been retracted and is not. Where a paper's abstract and results disagree, the results are used.

Office-based hand surgery under WALANT is a rare practice, and most hand surgeons are employed or work within integrated systems that favour the ambulatory surgery centre. Independent practices that do this work have had to build their own payer relationships, one at a time, often under confidentiality agreements. That takes years, and most surgeons who want to start never get the chance.

WSS was formed to give any practice a way in. It does not replace existing contracts or relationships. It brings new cases to surgeons who have none, and it gives surgeons who already have relationships a place to share the wider effort. More than 120 surgeons have already signed up to the network.

Our competition is not the other surgeons doing this work. It is the architecture of vertically integrated healthcare, which decides where surgery happens and who gets paid for it. Independent surgeons can only influence that by working together, and WSS is one way of doing that.